Andrew Woodhead
Publications by Year
Research Areas
Computational Drug Discovery Methods, Heat shock proteins research, Monoclonal and Polyclonal Antibodies Research, Click Chemistry and Applications, Cancer-related Molecular Pathways
Most-Cited Works
- → Recent Developments in Fragment-Based Drug Discovery(2008)605 cited
- → Identification of N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design(2008)337 cited
- → Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design(2010)261 cited
- → From fragment to clinical candidate—a historical perspective(2009)196 cited
- → Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation(2004)185 cited
- → Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency(2010)185 cited
- → Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function(2012)112 cited
- → Fragment-to-Lead Medicinal Chemistry Publications in 2022(2024)40 cited
- → Fragment-to-Lead Medicinal Chemistry Publications in 2021(2023)39 cited
- → Fragment-to-Lead Medicinal Chemistry Publications in 2023(2025)17 cited